glucose, (beta-d)-isomer has been researched along with butylhydroxybutylnitrosamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, S; Hagiwara, A; Ito, N; Kitaori, M; Shibata, M | 1 |
| Attalla, B; Bédard, A; Billger, M; Chang, J; Haile, S; Kirk, J; Söderberg, M | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and butylhydroxybutylnitrosamine
| Article | Year |
|---|---|
Effects of three sweeteners on rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Topics: Animals; Aspartame; Butylhydroxybutylnitrosamine; Diterpenes; Diterpenes, Kaurane; Glucosides; Hyperplasia; Male; Rats; Rats, Inbred F344; Saccharin; Sweetening Agents; Terpenes; Urinary Bladder; Urinary Bladder Neoplasms | 1984 |
A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.
Topics: Administration, Oral; Animals; Benzhydryl Compounds; Butylhydroxybutylnitrosamine; Disease Models, Animal; Dose-Response Relationship, Drug; Glucosides; Male; Rats; Rats, Sprague-Dawley; Urinary Bladder Neoplasms | 2019 |